Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • enabeler enabeler Dec 6, 2012 1:46 PM Flag

    Hey Duck, tried to reply to your "Hey Exelixis" post, but it got lost.

    In response to your "Hey Exelixis" post I think we should point out that Dr. Stelios Papadopoulis (EXEL chairman) and former chairman at ANDS was able to get a 300% premium for ANDS which had no approved drug or cash to speak of.

    I'm not saying he's trying to sell EXEL but his acumen as an investment banker for Paine Webber is pretty well known (as well as his scientific accomplishments) and stranger things have been known to happened.

    Sentiment: Strong Buy

 
EXEL
7.69-0.16(-2.04%)Jun 24 4:00 PMEDT